Toshiba showcases Titan
Vantage Titan, a wide-bore 1.5T scanner, highlights MR offerings from Toshiba America Medical Systems at the RSNA meeting this week. The work-in-progress features a bore 18% wider than any 1.5T scanner currently on the market, according to the company. A specially designed gradient system offers an amplitude of 30 and a slew rate of 130 to expand the field-of-view.
Vantage Titan, a wide-bore 1.5T scanner, highlights MR offerings from Toshiba America Medical Systems at the RSNA meeting this week. The work-in-progress features a bore 18% wider than any 1.5T scanner currently on the market, according to the company. A specially designed gradient system offers an amplitude of 30 and a slew rate of 130 to expand the field-of-view.
Engineers built the system around the same magnet that is currently available on Toshiba's Atlas MRs. This will allow Atlas owners to field-upgrade to the Titan when it is commercially offered, which could happen early next year. Titan includes Toshiba's proprietary sound-muffling technology, Pianissimo.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
